cancer cell-2016-A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
本文档由 Science 分享于2016-01-13 19:35
暂无简介
分享：
君，已阅读到文档的结尾了呢~~